Skip to main content
Erschienen in: Critical Care 4/2011

01.08.2011 | Review

Clinical review: Special populations - critical illness and pregnancy

verfasst von: Patrick J Neligan, John G Laffey

Erschienen in: Critical Care | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Critical illness is an uncommon but potentially devastating complication of pregnancy. The majority of pregnancy-related critical care admissions occur postpartum. Antenatally, the pregnant patient is more likely to be admitted with diseases non-specific to pregnancy, such as pneumonia. Pregnancy-specific diseases resulting in ICU admission include obstetric hemorrhage, pre-eclampsia/eclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, amniotic fluid embolus syndrome, acute fatty liver of pregnancy, and peripartum cardiomyopathy. Alternatively, critical illness may result from pregnancy-induced worsening of pre-existing diseases (for example, valvular heart disease, myasthenia gravis, and kidney disease). Pregnancy can also predispose women to diseases seen in the non-pregnant population, such as acute respiratory distress syndrome (for example, pneumonia and aspiration), sepsis (for example, chorioamnionitis and pyelonephritis) or pulmonary embolism. The pregnant patient may also develop conditions co-incidental to pregnancy such as trauma or appendicitis. Hemorrhage, particularly postpartum, and hypertensive disorders of pregnancy remain the most frequent indications for ICU admission. This review focuses on pregnancy-specific causes of critical illness. Management of the critically ill mother poses special challenges. The physiologic changes in pregnancy and the presence of a second, dependent, patient may necessitate adjustments to therapeutic and supportive strategies. The fetus is generally robust despite maternal illness, and therapeutically what is good for the mother is generally good for the fetus. For pregnancy-induced critical illnesses, delivery of the fetus helps resolve the disease process. Prognosis following pregnancy-related critical illness is generally better than for age-matched non-pregnant critically ill patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sriram S, Robertson MS: Critically ill obstetric patients in Australia: a retrospective audit of 8 years' experience in a tertiary intensive care unit. Crit Care Resusc. 2008, 10: 124-PubMed Sriram S, Robertson MS: Critically ill obstetric patients in Australia: a retrospective audit of 8 years' experience in a tertiary intensive care unit. Crit Care Resusc. 2008, 10: 124-PubMed
2.
Zurück zum Zitat Hazelgrove JF, Price C, Pappachan VJ, Smith GB: Multicenter study of obstetric admissions to 14 intensive care units in southern England. Crit Care Med. 2001, 29: 770-775. 10.1097/00003246-200104000-00016.PubMedCrossRef Hazelgrove JF, Price C, Pappachan VJ, Smith GB: Multicenter study of obstetric admissions to 14 intensive care units in southern England. Crit Care Med. 2001, 29: 770-775. 10.1097/00003246-200104000-00016.PubMedCrossRef
3.
Zurück zum Zitat Tang LC, Kwok AC, Wong AY, Lee YY, Sun KO, So AP: Critical care in obstetrical patients: an eight-year review. Chin Med J (Engl). 1997, 110: 936-941. Tang LC, Kwok AC, Wong AY, Lee YY, Sun KO, So AP: Critical care in obstetrical patients: an eight-year review. Chin Med J (Engl). 1997, 110: 936-941.
5.
Zurück zum Zitat Wissa I, Ebeid E, El-Shawarby S, Chandakas S, Kamal T, Hill N: The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience. J Obstet Gynaecol. 2009, 29: 21-24. 10.1080/01443610802628692.PubMedCrossRef Wissa I, Ebeid E, El-Shawarby S, Chandakas S, Kamal T, Hill N: The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience. J Obstet Gynaecol. 2009, 29: 21-24. 10.1080/01443610802628692.PubMedCrossRef
6.
Zurück zum Zitat Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K: Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. J Obstet Gynaecol Res. 2008, 34: 623-630. 10.1111/j.1447-0756.2008.00896.x.PubMedCrossRef Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K: Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. J Obstet Gynaecol Res. 2008, 34: 623-630. 10.1111/j.1447-0756.2008.00896.x.PubMedCrossRef
7.
Zurück zum Zitat Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol. 2008, 48: 12-16. 10.1111/j.1479-828X.2007.00823.x.PubMedCrossRef Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol. 2008, 48: 12-16. 10.1111/j.1479-828X.2007.00823.x.PubMedCrossRef
8.
Zurück zum Zitat Duley L: Magnesium sulphate in eclampsia. Eclampsia Trial Collaborative Group. Lancet. 1998, 352: 67-68.PubMedCrossRef Duley L: Magnesium sulphate in eclampsia. Eclampsia Trial Collaborative Group. Lancet. 1998, 352: 67-68.PubMedCrossRef
9.
10.
Zurück zum Zitat Fonseca JE, Mendez F, Catano C, Arias F: Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a doubleblind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005, 193: 1591-1598. 10.1016/j.ajog.2005.07.037.PubMedCrossRef Fonseca JE, Mendez F, Catano C, Arias F: Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a doubleblind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005, 193: 1591-1598. 10.1016/j.ajog.2005.07.037.PubMedCrossRef
11.
Zurück zum Zitat Ibdah JA: Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol. 2006, 12: 7397-7404.PubMedPubMedCentral Ibdah JA: Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol. 2006, 12: 7397-7404.PubMedPubMedCentral
12.
Zurück zum Zitat Treem WR, Shoup ME, Hale DE, Bennett MJ, Rinaldo P, Millington DS, Stanley CA, Riely CA, Hyams JS: Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency. Am J Gastroenterol. 1996, 91: 2293-2300.PubMed Treem WR, Shoup ME, Hale DE, Bennett MJ, Rinaldo P, Millington DS, Stanley CA, Riely CA, Hyams JS: Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency. Am J Gastroenterol. 1996, 91: 2293-2300.PubMed
13.
Zurück zum Zitat Cappell MS: Hepatic disorders severely affected by pregnancy: medical and obstetric management. Med Clin North Am. 2008, 92: 739-viii. 10.1016/j.mcna.2008.03.002.PubMedCrossRef Cappell MS: Hepatic disorders severely affected by pregnancy: medical and obstetric management. Med Clin North Am. 2008, 92: 739-viii. 10.1016/j.mcna.2008.03.002.PubMedCrossRef
14.
Zurück zum Zitat Hamid SS, Jafri SM, Khan H, Shah H, Abbas Z, Fields H: Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?. J Hepatol. 1996, 25: 20-27. 10.1016/S0168-8278(96)80323-0.PubMedCrossRef Hamid SS, Jafri SM, Khan H, Shah H, Abbas Z, Fields H: Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?. J Hepatol. 1996, 25: 20-27. 10.1016/S0168-8278(96)80323-0.PubMedCrossRef
15.
Zurück zum Zitat Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF: Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995, 172: 1158-1167. 10.1016/0002-9378(95)91474-9.PubMedCrossRef Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF: Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995, 172: 1158-1167. 10.1016/0002-9378(95)91474-9.PubMedCrossRef
16.
Zurück zum Zitat Aurangzeb I, George L, Raoof S: Amniotic fluid embolism. Crit Care Clin. 2004, 20: 643-650. 10.1016/j.ccc.2004.06.002.PubMedCrossRef Aurangzeb I, George L, Raoof S: Amniotic fluid embolism. Crit Care Clin. 2004, 20: 643-650. 10.1016/j.ccc.2004.06.002.PubMedCrossRef
17.
Zurück zum Zitat Clark SL: New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv. 1990, 45: 360-368. 10.1097/00006254-199006000-00003.PubMedCrossRef Clark SL: New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv. 1990, 45: 360-368. 10.1097/00006254-199006000-00003.PubMedCrossRef
18.
Zurück zum Zitat Stroup J, Haraway D, Beal JM: Aprotinin in the management of coagulopathy associated with amniotic fluid embolus. Pharmacotherapy. 2006, 26: 689-693. 10.1592/phco.26.5.689.PubMedCrossRef Stroup J, Haraway D, Beal JM: Aprotinin in the management of coagulopathy associated with amniotic fluid embolus. Pharmacotherapy. 2006, 26: 689-693. 10.1592/phco.26.5.689.PubMedCrossRef
19.
Zurück zum Zitat Hsieh YY, Chang CC, Li PC, Tsai HD, Tsai CH: Successful application of extracorporeal membrane oxygenation and intra-aortic balloon counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol. 2000, 183: 496-497. 10.1067/mob.2000.104834.PubMedCrossRef Hsieh YY, Chang CC, Li PC, Tsai HD, Tsai CH: Successful application of extracorporeal membrane oxygenation and intra-aortic balloon counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol. 2000, 183: 496-497. 10.1067/mob.2000.104834.PubMedCrossRef
20.
Zurück zum Zitat Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000, 283: 1183-1188. 10.1001/jama.283.9.1183.PubMedCrossRef Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000, 283: 1183-1188. 10.1001/jama.283.9.1183.PubMedCrossRef
21.
Zurück zum Zitat Hilfiker-Kleiner D, Sliwa K, Drexler H: Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med. 2008, 18: 173-179. 10.1016/j.tcm.2008.05.002.PubMedCrossRef Hilfiker-Kleiner D, Sliwa K, Drexler H: Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med. 2008, 18: 173-179. 10.1016/j.tcm.2008.05.002.PubMedCrossRef
22.
Zurück zum Zitat Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007, 128: 589-600. 10.1016/j.cell.2006.12.036.PubMedCrossRef Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007, 128: 589-600. 10.1016/j.cell.2006.12.036.PubMedCrossRef
23.
Zurück zum Zitat Smith IJ, Gillham MJ: Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation. Int J Obstet Anesth. 2009, 18: 186-188. 10.1016/j.ijoa.2008.11.007.PubMedCrossRef Smith IJ, Gillham MJ: Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation. Int J Obstet Anesth. 2009, 18: 186-188. 10.1016/j.ijoa.2008.11.007.PubMedCrossRef
24.
Zurück zum Zitat Jahns BG, Stein W, Hilfiker-Kleiner D, Pieske B, Emons G: Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol. 2008, 199: e5-e6.PubMedCrossRef Jahns BG, Stein W, Hilfiker-Kleiner D, Pieske B, Emons G: Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol. 2008, 199: e5-e6.PubMedCrossRef
25.
Zurück zum Zitat Ro A, Frishman WH: Peripartum cardiomyopathy. Cardiol Rev. 2006, 14: 35-42. 10.1097/01.crd.0000174805.68081.f7.PubMedCrossRef Ro A, Frishman WH: Peripartum cardiomyopathy. Cardiol Rev. 2006, 14: 35-42. 10.1097/01.crd.0000174805.68081.f7.PubMedCrossRef
26.
Zurück zum Zitat Bryan CS, Reynolds KL, Moore EE: Bacteremia in obstetrics and gynecology. Obstet Gynecol. 1984, 64: 155-158.PubMed Bryan CS, Reynolds KL, Moore EE: Bacteremia in obstetrics and gynecology. Obstet Gynecol. 1984, 64: 155-158.PubMed
27.
Zurück zum Zitat Blanco JD, Gibbs RS, Castaneda YS: Bacteremia in obstetrics: clinical course. Obstet Gynecol. 1981, 58: 621-625.PubMed Blanco JD, Gibbs RS, Castaneda YS: Bacteremia in obstetrics: clinical course. Obstet Gynecol. 1981, 58: 621-625.PubMed
28.
Zurück zum Zitat Monif GR, Baer H: Polymicrobial bacteremia in obstetric patients. Obstet Gynecol. 1976, 48: 167-169.PubMed Monif GR, Baer H: Polymicrobial bacteremia in obstetric patients. Obstet Gynecol. 1976, 48: 167-169.PubMed
29.
Zurück zum Zitat Ledger WJ, Norman M, Gee C, Lewis W: Bacteremia on an obstetric-gynecologic service. Am J Obstet Gynecol. 1975, 121: 205-212.PubMed Ledger WJ, Norman M, Gee C, Lewis W: Bacteremia on an obstetric-gynecologic service. Am J Obstet Gynecol. 1975, 121: 205-212.PubMed
30.
Zurück zum Zitat Mabie WC, Barton JR, Sibai B: Septic shock in pregnancy. Obstet Gynecol. 1997, 90: 553-561. 10.1016/S0029-7844(97)00352-9.PubMedCrossRef Mabie WC, Barton JR, Sibai B: Septic shock in pregnancy. Obstet Gynecol. 1997, 90: 553-561. 10.1016/S0029-7844(97)00352-9.PubMedCrossRef
31.
Zurück zum Zitat Kankuri E, Kurki T, Carlson P, Hiilesmaa V: Incidence, treatment and outcome of peripartum sepsis. Acta Obstet Gynecol Scand. 2003, 82: 730-735. 10.1034/j.1600-0412.2003.00265.x.PubMedCrossRef Kankuri E, Kurki T, Carlson P, Hiilesmaa V: Incidence, treatment and outcome of peripartum sepsis. Acta Obstet Gynecol Scand. 2003, 82: 730-735. 10.1034/j.1600-0412.2003.00265.x.PubMedCrossRef
32.
Zurück zum Zitat Centre for Maternal and Child Enquiries (CMACE): Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011, 118 (Suppl 1): 1-203. Centre for Maternal and Child Enquiries (CMACE): Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011, 118 (Suppl 1): 1-203.
34.
Zurück zum Zitat Zdolsek HJ, Holmgren S, Wedenberg K, Lennmarken C: Circulatory arrest in late pregnancy: caesarean section a vital decision for both mother and child. Acta Anaesthesiol Scand. 2009, 53: 828-829. 10.1111/j.1399-6576.2009.01970.x.PubMedCrossRef Zdolsek HJ, Holmgren S, Wedenberg K, Lennmarken C: Circulatory arrest in late pregnancy: caesarean section a vital decision for both mother and child. Acta Anaesthesiol Scand. 2009, 53: 828-829. 10.1111/j.1399-6576.2009.01970.x.PubMedCrossRef
35.
Zurück zum Zitat McDonnell NJ: Cardiopulmonary arrest in pregnancy: two case reports of successful outcomes in association with perimortem Caesarean delivery. Br J Anaesth. 2009, 103: 406-409. 10.1093/bja/aep176.PubMedCrossRef McDonnell NJ: Cardiopulmonary arrest in pregnancy: two case reports of successful outcomes in association with perimortem Caesarean delivery. Br J Anaesth. 2009, 103: 406-409. 10.1093/bja/aep176.PubMedCrossRef
36.
Zurück zum Zitat Bush MC, Nagy S, Berkowitz RL, Gaddipati S: Pregnancy in a persistent vegetative state: case report, comparison to brain death, and review of the literature. Obstet Gynecol Surv. 2003, 58: 738-748. 10.1097/01.OGX.0000093268.20608.53.PubMedCrossRef Bush MC, Nagy S, Berkowitz RL, Gaddipati S: Pregnancy in a persistent vegetative state: case report, comparison to brain death, and review of the literature. Obstet Gynecol Surv. 2003, 58: 738-748. 10.1097/01.OGX.0000093268.20608.53.PubMedCrossRef
37.
Zurück zum Zitat Farragher R, Marsh B, Laffey JG: Maternal brain death--an Irish perspective. Ir J Med Sci. 2005, 174: 55-59.PubMedCrossRef Farragher R, Marsh B, Laffey JG: Maternal brain death--an Irish perspective. Ir J Med Sci. 2005, 174: 55-59.PubMedCrossRef
38.
Zurück zum Zitat Mallampalli A, Guy E: Cardiac arrest in pregnancy and somatic support after brain death. Crit Care Med. 2005, 33: S325-S331. 10.1097/01.CCM.0000182788.31961.88.PubMedCrossRef Mallampalli A, Guy E: Cardiac arrest in pregnancy and somatic support after brain death. Crit Care Med. 2005, 33: S325-S331. 10.1097/01.CCM.0000182788.31961.88.PubMedCrossRef
Metadaten
Titel
Clinical review: Special populations - critical illness and pregnancy
verfasst von
Patrick J Neligan
John G Laffey
Publikationsdatum
01.08.2011
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 4/2011
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10256

Weitere Artikel der Ausgabe 4/2011

Critical Care 4/2011 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.